Maciejewski ML, Arterburn DE, Van Scoyoc L, Smith VA, Yancy WS Jr, Weidenbacher HJ, et al
Rub gently over the face, neck, ears, and whole body Rubbing harder and longer over heavily darkened and blemished areas Rinse well with water Use daily for washing face and bathing
Trial design and major outcomes Six major randomized control trials, ELIXA (The Evaluation of Lixisenatide in Acute Coronary Syndrome), LEADER (Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes), SUSTAIN-6 (Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes), EXSCEL (Exenatide Study of Cardiovascular Event Lowering), HARMONY (Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease), and REWIND (Dulaglutide and cardiovascular outcomes in type 2 diabetes) have investigated cardiovascular outcomes in patients treated with injectable GLP1 agonists (5358)
Lu, S., Yin, H., Yu, O
Can We Convince My Insurance to Cover a Brand Name GLP-1
The placebo group recorded only a 4.5% reduction in total fat mass, while retatrutide recipients saw fat mass fall by 15.2% in the 4mg group, 26.1% in the 8mg group and 23.2% in the 12mg group